Skip to main content
OpenTrials

Clinical trial condition

Glomerulonephritis

Explore clinical trials studying Glomerulonephritis. Study availability and eligibility vary by location and protocol.

496 public trials 165 recruiting studies
Refine in advanced search Browse all conditions

Glomerulonephritis trial results

Completed

Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN)

NCT04145440

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • North America Research Institute Azusa, California, United States
  • UCSF Medical Center San Francisco, California, United States
  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Torrance, California, United States
  • University of Miami Division of Nephrology & Hypertension Miami, Florida, United States
View all 45 locations
View Trial Details
Completed

Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies

NCT03453619

Conditions
Autoimmune Diseases, C3 Glomerulonephritis, Connective Tissue Diseases, +18 more
Locations
  • Stanford University Stanford, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • HealthONE Physician Care, Rocky Mountain Hospital for Children Denver, Colorado, United States
  • Washington Nephrology Associates Washington D.C., District of Columbia, United States
View all 17 locations
View Trial Details
Completed

Efficacy and Safety in Patients With Primary IgA Nephropathy Who Have Completed Study Nef-301 (Nefigard-OLE)

NCT04541043

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • 13 Investigator sites Palo Alto, California, United States
  • 4 Investigator sites Buenos Aires, Argentina
  • 6 Investigator sites Melbourne, Australia
  • 3 Investigator sites Minsk, Belarus
View all 18 locations
View Trial Details
Completed

A Study to Evaluate the Effectiveness and Safety of IONIS-FB-LRx, an Antisense Inhibitor of Complement Factor B, in Adult Participants With Primary IgA Nephropathy

NCT04014335

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • IONIS Investigative Site Liverpool, New South Wales, Australia
  • IONIS Investigative Site St Leonards, New South Wales, Australia
  • IONIS Investigative Site Parkville, Victoria, Australia
  • IONIS Investigative Site Vancouver, British Columbia, Canada
View Trial Details
Completed

Evaluation of the Pharmacokinetics and Safety of Inaxaplin in Participants With Mild or Moderate Hepatic Impairment

NCT06529796

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Focal Segmental Glomerulosclerosis (FSGS), +7 more
Locations
  • Division of Clinical Pharmacology, University of Miami Miami, Florida, United States
  • GCP Research St. Petersburg, Florida, United States
  • Texas Liver Institute San Antonio, Texas, United States
View Trial Details

Related conditions